IBTmes India
Biocon Biologics gets EMA nod to manufacture cancer drug in India
7 days ago
The Economic Times
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
India Telecom News
EMA Approves Biocon Biologics to Produce Biosimilar Bevacizumab - India Telecom News
In Short:Biocon Biologics, a subsidiary of Biocon Ltd, has gotten approval from the European Medicines Agency to produce ...
6 days ago
Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld | Pharma
CNBC Awaaz
Vedanta mulls first dollar bond sale of $500 million
Sony Pictures Networks India appoints Gaurav Banerjee as new MD & CEO
View all